Deltex Medical Group plc
DTXMF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $4,551 | $4,496 | $1,700 | $4,439 |
| - Cash | $242 | $326 | $705 | $107 |
| + Debt | $2,011 | $1,983 | $1,921 | $2,348 |
| Enterprise Value | $6,320 | $6,153 | $2,916 | $6,680 |
| Revenue | $992 | $1,064 | $359 | $1,059 |
| % Growth | -6.8% | 196.8% | -66.1% | – |
| Gross Profit | $687 | $711 | $36 | $708 |
| % Margin | 69.3% | 66.8% | 9.9% | 66.9% |
| EBITDA | -$404 | -$403 | -$123 | -$151 |
| % Margin | -40.7% | -37.9% | -34.3% | -14.2% |
| Net Income | -$1,251 | -$546 | -$719 | -$538 |
| % Margin | -126.1% | -51.3% | -200.6% | -50.8% |
| EPS Diluted | -0.001 | -0 | -0 | -0.001 |
| % Growth | -133.3% | 25% | 50% | – |
| Operating Cash Flow | -$46 | -$435 | -$890 | -$305 |
| Capital Expenditures | -$9 | $0 | -$128 | -$242 |
| Free Cash Flow | -$55 | -$435 | -$1,018 | -$547 |